SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-15-000124
Filing Date
2015-02-13
Accepted
2015-02-13 15:27:14
Documents
1
Group Members
ALEX ZISSONERIC AGUIARJAMES E. THOMASPETER MCNERNEYTHOMAS MCNERNEY & PARTNERS II L.P.THOMAS MCNERNEY & PARTNERS II LLCTHOMAS MCNERNEY & PARTNERS LLCTMP ASSOCIATES II L.P.TMP ASSOCIATES L.P.TMP NOMINEE II LLCTMP NOMINEE LLC

Document Format Files

Seq Description Document Type Size
1 OCERA THERAPEUTICS, INC. - AMEND. NO. 1 ocera-sch13da_17765.htm SC 13D/A 465873
  Complete submission text file 0001072613-15-000124.txt   467718
Mailing Address
Business Address 60 S SIXTH ST SUITE 3510 MINNEAPOLIS MN 55402 6123358666
THOMAS MCNERNEY & PARTNERS LP (Filed by) CIK: 0001231291 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Subject) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86177 | Film No.: 15613516
SIC: 2834 Pharmaceutical Preparations